Medical decisions are made by independent licensed providers
At $15-50 per month, phentermine is accessible to almost everyone
Researchers including Nora Volkow, the director of the National Institute on Drug Abuse, now report[i] indications that semaglutide (Ozempic), which increases insulin secretion, may have uses beyond its 2017 FDA approval for obesity and type 2 diabetes
Robust clinical trials with well-defined endometrial receptivity endpoints and pregnancy outcomes are required before these approaches can be translated into routine clinical practice
Tirzepatide may have a slightly higher incidence of nausea due to its dual-agonist mechanism
While digestive enzymes while on GLP-1 therapy are sometimes considered, understanding the evidence, safety considerations, and proven management strategies is essential before adding supplements to your treatment regimen